Search alternatives:
canadian » canada

62
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The CADTH Canadian Drug Expert Committee recommends that inotersen be reimbursed for the treatment...

63
Published 2020
CADTH
...The CADTH Canadian Drug Expert Committee (CDEC) recommends that safinamide should not be reimbursed...

66
Published 2017
Canadian Agency for Drugs and Technologies in Health
...The CADTH Canadian Drug Expert Committee (CDEC) recommends that nusinersen be reimbursed...

67
Published 2021
Canadian Agency for Drugs and Technologies in Health
...The CADTH Canadian Drug Expert Committee (CDEC) recommends that ranolazine not be reimbursed as add...

68
Published 2018
CADTH
...The CADTH Canadian Drug Expert Committee (CDEC) recommends that nitisinone (Orfadin) be reimbursed...

69
Published 2011
Canadian Agency for Drugs and Technologies in Health

70
Published 2014
Canadian Agency for Drugs and Technologies in Health

71
Published 2015
Canadian Agency for Drugs and Technologies in Health
.... In 2008, over 300,000 Canadians were residing in long-term care facilities, a population prone to falling...

72
Published 2016
Canadian Agency for Drugs and Technologies in Health

73
Published 2016
Canadian Agency for Drugs and Technologies in Health

74
Published 2015
CADTH Rapid Response Service
... estimated that 6-8% of patients with chronic pain experience NP in the general population. A single Canadian...

75
Published 2015
CADTH Rapid Response Service
... estimated that 6-8% of patients with chronic pain experience NP in the general population. A single Canadian...

76
Published 2017
Canadian Agency for Drugs and Technologies in Health
...CADTH Canadian Drug Expert Committee final recommendation...

77
Published 2017
Canadian Agency for Drugs and Technologies in Health

78
Published 2014
Canadian Agency for Drugs and Technologies in Health

79
Published 2016
Canadian Agency for Drugs and Technologies in Health

80
Published 2017
Canadian Agency for Drugs and Technologies in Health